Patient case study - Patient with PAD at risk of CV events
PAD is a complication of T2D and a predictor of CV events. This interactive module explores the care of a patient with PAD at risk of CV events.
Introduction
Disclaimer
How to use this case study
Marie
Marie – appointment 1
Marie – you examine Marie
Marie – you review Marie’s recent blood test results
Marie – management considerations
Marie – management considerations
Marie – management considerations
Marie – management considerations
Marie – management considerations
Marie – management considerations
Marie – 6 weeks later…
Marie – letter from the vascular surgeon
Marie – 6 weeks later…
Marie – you examine Marie’s foot
Marie – you review Marie’s recent blood test results
Marie – management considerations
Marie – management considerations
Marie – management considerations
Marie – management considerations (1/2)
Marie – management considerations (2/2)
In patients with symptomatic PAD, single antiplatelet therapy is recommended
Evidence−grading system
Guidelines recommend a multifactorial strategy to reduce increased CV risk in patients with PAD
Patients with T2D and PAD are at increased risk of foot ulcers
Discussion
Guidelines emphasise the importance of CV disease risk management in patients with T2D
For patients with T2D and CV disease, guidelines recommend an agent proven to reduce CV events/mortality
Marie – patient case learning points